According to Oxford University, the trials could yield results as soon as mid-August. But the real question is whether the vaccine would be effective against the novel discovered SARS-CoV-2 virus.
According to a report, scientists at Oxford University have produced a million doses of the vaccine because they believe the vaccine will prove successful and will be available in September. The report states that more than 500 British volunteers will receive the first dose of vaccine within the first week of launch.
The Recovery Trial will test four drugs, including anti-malarial drug hydroxychloroquine, the steroid dexamethasone, the antibiotic azithromycin and lopinavir-ritonavir commonly used to treat HIV.
The World Health Organization (WHO) said that currently at least 70 potential vaccines under the works, with three of which are already in human trials.
The COVID-19 pandemic caused by the SARS-CoV-2 virus has affected almost all countries with more than two million confirmed cases and 164,016 deaths worldwide.